BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 8227489)

  • 1. Possible monoamine oxidase inhibitor-serotonin uptake inhibitor interaction: fluoxetine clinical data and preclinical findings.
    Beasley CM; Masica DN; Heiligenstein JH; Wheadon DE; Zerbe RL
    J Clin Psychopharmacol; 1993 Oct; 13(5):312-20. PubMed ID: 8227489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse consequences of fluoxetine-MAOI combination therapy.
    Feighner JP; Boyer WF; Tyler DL; Neborsky RJ
    J Clin Psychiatry; 1990 Jun; 51(6):222-5. PubMed ID: 2347858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuation and maintenance treatments in major depression: the neglected role of monoamine oxidase inhibitors.
    Kennedy SH
    J Psychiatry Neurosci; 1997 Mar; 22(2):127-31. PubMed ID: 9074307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Refractory depression treated with high doses of monoamine oxidase inhibitor.
    Guze BH; Baxter LR; Rego J
    J Clin Psychiatry; 1987 Jan; 48(1):31-2. PubMed ID: 3804984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies for fluoxetine-MAOI combination therapy.
    Peterson GN
    J Clin Psychiatry; 1991 Feb; 52(2):87-8. PubMed ID: 1993642
    [No Abstract]   [Full Text] [Related]  

  • 6. The safety of switching rapidly from tricyclic antidepressants to monoamine oxidase inhibitors.
    Kahn D; Silver JM; Opler LA
    J Clin Psychopharmacol; 1989 Jun; 9(3):198-202. PubMed ID: 2738181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Abuse of the monoamine oxidase (MAOI) inhibitors as antidepressive drugs: a critical review].
    García-Campayo JJ; Sanz-Carrillo C; Ferrández Payo M
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1995; 23(4):217-22. PubMed ID: 7484306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid conversion from one monoamine oxidase inhibitor to another.
    Szuba MP; Hornig-Rohan M; Amsterdam JD
    J Clin Psychiatry; 1997 Jul; 58(7):307-10. PubMed ID: 9269251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse interaction of cyproheptadine with serotonergic antidepressants.
    Katz RJ; Rosenthal M
    J Clin Psychiatry; 1994 Jul; 55(7):314-5. PubMed ID: 8071295
    [No Abstract]   [Full Text] [Related]  

  • 10. Adverse reactions to monoamine oxidase inhibitors. Part I. A comparative study.
    Rabkin J; Quitkin F; Harrison W; Tricamo E; McGrath P
    J Clin Psychopharmacol; 1984 Oct; 4(5):270-8. PubMed ID: 6386898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute cardiovascular response to monoamine oxidase inhibitors: a prospective assessment.
    Keck PE; Vuckovic A; Pope HG; Nierenberg AA; Gribble GW; White K
    J Clin Psychopharmacol; 1989 Jun; 9(3):203-6. PubMed ID: 2738182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of monoamine oxidase inhibitor-associated insomnia with trazodone.
    Nierenberg AA; Keck PE
    J Clin Psychopharmacol; 1989 Feb; 9(1):42-5. PubMed ID: 2708555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Elderly patients, classical monoamine oxidase inhibitors and intercurrent somatic diseases].
    Oostervink F; Bouvy PF; Touw DJ
    Ned Tijdschr Geneeskd; 2003 Oct; 147(40):1937-40. PubMed ID: 14574773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of high-intensity treatment with the irreversible monoamine oxidase inhibitor tranylcypromine in patients with treatment-resistant depression.
    Adli M; Pilhatsch M; Bauer M; Köberle U; Ricken R; Janssen G; Ulrich S; Bschor T
    Pharmacopsychiatry; 2008 Nov; 41(6):252-7. PubMed ID: 19067263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of a brief survey on the prescribing practices for monoamine oxidase inhibitor antidepressants.
    Clary C; Mandos LA; Schweizer E
    J Clin Psychiatry; 1990 Jun; 51(6):226-31. PubMed ID: 2347859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mysterious MAOI hypertensive episodes.
    Linet LS
    J Clin Psychiatry; 1986 Nov; 47(11):563-5. PubMed ID: 3095312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcutaneous sumatriptan pharmacokinetics: delimiting the monoamine oxidase inhibitor effect.
    Fox AW
    Headache; 2010 Feb; 50(2):249-55. PubMed ID: 19925626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined MAOI, TCA, and direct stimulant therapy of treatment-resistant depression.
    Feighner JP; Herbstein J; Damlouji N
    J Clin Psychiatry; 1985 Jun; 46(6):206-9. PubMed ID: 3997787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of MAOI hypertensive crisis with sublingual nifedipine.
    Clary C; Schweizer E
    J Clin Psychiatry; 1987 Jun; 48(6):249-50. PubMed ID: 3584082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two cases of hypomania following the addition of L-tryptophan to a monoamine oxidase inhibitor.
    Goff DC
    Am J Psychiatry; 1985 Dec; 142(12):1487-8. PubMed ID: 4073318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.